Plural participates in Everlab’s AU$65 million Series A funding round
Everlab, an Australian healthtech company building a preventative and personalised healthcare platform, has raised AU$65 million in Series A funding. The oversubscribed round was led by Airtree Ventures, with participation from EstVCA member Plural, existing investors Left Lane Capital and b2venture, and several angel investors.
Founded in Melbourne in 2023, Everlab is developing a digital healthcare platform that combines diagnostics, clinicians, specialists, prescriptions, wearable data, and AI-powered care into a single patient experience. The company aims to shift healthcare from a reactive, illness-focused system to a preventive model focused on improving long-term health outcomes.
Today, Everlab's platform integrates with more than 1,850 healthcare provider locations, works with over 180 active clinicians, connects to more than 30 wearable devices, and processes over 200,000 health reports every month. Since its launch, the company has completed more than 40,000 consultations for over 20,000 patients and corporate clients, including Boston Consulting Group, BHP, and Bain & Company. Everlab has also processed more than 21 million biomarker test results, with over a quarter of members receiving clinically significant findings that had not been identified through the traditional healthcare system.
“We built Everlab to hold the full picture, surface health blind spots and coordinate what needs to happen next — from targeted screenings to personalised health plans — helping more people live longer, healthier lives,” said Marc Hermann, Co-founder and CEO of Everlab.
The funding will support the expansion of Everlab's clinical and technology infrastructure and accelerate its international growth, beginning with the United Kingdom.
“Every company that has tried to own the patient journey has ended up either selling doctor time by the minute or reselling lab tests with thin margins,” said Carina Namih, Partner at Plural. “Everlab is building the layer above both: the system that interprets and coordinates your health data over time, rather than capturing a single transaction. The fact that they’ve already proven their model operationally in Australia, at scale, is what convinced me this is the version that genuinely works.”
The round reflects growing investor interest in technology platforms that use data, AI, and continuous care models to improve preventative healthcare and patient outcomes at scale.
